MEI Pharma Inc (MEIP) — Cash Flow Quality Index
MEI Pharma Inc (MEIP) has a Cash Flow Quality Index of -0.33x as of September 2023. Operating cash flow of $-18.49 Million is below net income of $56.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore MEI Pharma Inc (MEIP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
MEI Pharma Inc Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for MEI Pharma Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see MEI Pharma Inc (MEIP) cash flow conversion.
Annual Cash Flow Quality Index for MEI Pharma Inc (2017–2024)
Year-by-year earnings quality comparison for MEI Pharma Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -2.84x | $-50.47 Million | $17.78 Million | ▼ -317.5% |
| 2017 | 1.31x | $3.49 Million | $2.67 Million | — |